Pfizer's COVID pill Paxlovid gets boost in Britain thanks to spot in national trial - FiercePharma
Pfizer’s COVID-19 vaccine and antiviral show little sign of slowing down in the pandemic’s third year. Now, the company’s oral therapy is getting a boost across the Atlantic. | Thousands more people in the U.K. will gain access to Pfizer’s COVID antiviral Pax…
Read More
Other Stories in Health
- Alcohol consumption higher in regional and affluent areas, wastewater analysis reveals
- Novel gene-delivery vehicle shows promise for treating brain disorders
- Stanford Health Care Nurse Residency Cohort 41
- Fatty liver alert: Swelling in these body parts can indicate severe disease
- New study uncovers 17 genes driving clonal hematopoiesis and links to aging and disease
- UT Southwestern Medical Center (UTSW) July 2024 Residency Cohort
- How to Start Saying No When You’re Afraid of Disapproval
- Sleep and anesthesia hinder brain toxin clearance, study reveals
- Healthy Pasta Recipe: This Zero-Oil Romesco Pasta Will Make Your Binge-Eating Sessions Guilt-Free
.png)
